Ab Initio Pharma Announces Sponsorship of the 2024 NSW Drug Discovery Forum Commercialisation Award
Ab Initio Pharma is proud to sponsor the 2024 NSW Drug Discovery Forum with the launch of the ABVANCE Commercialisation Award. This prestigious award will grant the winning research team $20,000 in Ab Initio services to propel their innovative therapeutic research to the next level of development.
The NSW Drug Discovery Forum, presented by the Centre for Drug Discovery Innovation in partnership with MTP Connect, is the first event of its kind in New South Wales. This annual forum provides a unique platform for academic researchers in drug discovery to connect directly with industry professionals and investors. By presenting their groundbreaking research to a panel of industry experts, researchers receive invaluable feedback at a critical stage in the drug discovery process, where industry insight and expertise can be the key to success.
This year's forum will focus on the following therapeutic areas: Oncology; Central Nervous System and Neurological Disorders; Inflammation; Infectious Diseases; Cardiovascular and Metabolic Disorders.
With an attendance of over 150 delegates, presenters, and industry representatives, the event brings together a diverse group of professionals from various career levels, institutions, and research disciplines. The Forum will take place on the 28-29th of October, 2024 at The University of Sydney Camperdown Campus.
About Ab Initio Pharma: Ab Initio Pharma is the leading Australian GMP CDMO specialising in complex formulation product development and GMP manufacture. Ab Initio can help with all phases of your product development from regulatory strategy, IND-enabling studies, CMC, technical and intellectual property support, and clinical trial assistance. The company is dedicated to empowering researchers and spin-offs by providing the essential services needed to bring innovative therapies to market.
Ab Initio is thrilled to support the NSW Drug Discovery Forum and to offer our expertise through our ABVANCE Commercialisation Award. Our goal is to help innovative researchers navigate the complexities of drug development, and we believe this award will provide the winning team with the resources and support they need to make a significant impact.
